201 related articles for article (PubMed ID: 19667654)
1. Metabolic studies of atypical antipsychotic agents and diabetes.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):72-9. PubMed ID: 19667654
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotics and diabetes: case reports and cohort studies.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):59-71. PubMed ID: 19667653
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics and diabetes mellitus.
Lichiardopol R
Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
[TBL] [Abstract][Full Text] [Related]
4. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
Silvestre JS; Prous J
Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
[TBL] [Abstract][Full Text] [Related]
5. [Diabetes mellitus type II--induced by "atypical" neuroleptics?].
Wetterling T
Fortschr Neurol Psychiatr; 2003 Jun; 71(6):312-22. PubMed ID: 12796851
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
7. Directions for future research.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):85-6. PubMed ID: 19667657
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics and glucose homeostasis.
Bergman RN; Ader M
J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
[TBL] [Abstract][Full Text] [Related]
9. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.
Edward KL; Rasmussen B; Munro I
Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688
[TBL] [Abstract][Full Text] [Related]
10. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
[TBL] [Abstract][Full Text] [Related]
11. Metabolic side effects of atypical antipsychotics in children: a literature review.
Fedorowicz VJ; Fombonne E
J Psychopharmacol; 2005 Sep; 19(5):533-50. PubMed ID: 16166191
[TBL] [Abstract][Full Text] [Related]
12. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
13. Association between antipsychotic drugs and diabetes.
Holt RI; Peveler RC
Diabetes Obes Metab; 2006 Mar; 8(2):125-35. PubMed ID: 16448516
[TBL] [Abstract][Full Text] [Related]
14. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
15. [Glucose intolerance with antipsychotic drugs].
Naitoh H; Manabe Y; Iwata N
Nihon Rinsho; 2005 Feb; 63 Suppl 2():329-32. PubMed ID: 15779397
[No Abstract] [Full Text] [Related]
16. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
18. Study focuses in on potential cause of antipsychotic-induced diabetes.
O'Neill MF
Drug News Perspect; 2005 Oct; 18(8):481-2. PubMed ID: 16391716
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics and weight gain.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of antipsychotics.
Michelsen JW; Meyer JM
Expert Rev Neurother; 2007 Jul; 7(7):829-39. PubMed ID: 17610390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
